31 – 40 of 41
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
The CCND1 c.870G > A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma
(
- Contribution to journal › Article
-
Mark
Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Deciphering the 8q24.21 association for glioma
(
- Contribution to journal › Article
- 2012
-
Mark
Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk
(
- Contribution to journal › Article
-
Mark
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma
(
- Contribution to journal › Letter
-
Mark
Genome-wide association study identifies a common variant in RAD51B associated with male breast cancer risk
(
- Contribution to journal › Article
- 2010
-
Mark
Verification that common variation at 2q37.1, 6p25.3, 11q24.1, 15q23, and 19q13.32 influences chronic lymphocytic leukaemia risk
(
- Contribution to journal › Article
-
Mark
Verification of the susceptibility loci on 7p12.2, 10q21.2, and 14q11.2 in precursor B-cell acute lymphoblastic leukemia of childhood
(
- Contribution to journal › Article
-
Mark
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
(
- Contribution to journal › Article
-
Mark
Variation in CDKN2A at 9p21.3 influences childhood acute lymphoblastic leukemia risk
(
- Contribution to journal › Article